| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.45▼ | 1.47▼ | 1.47▼ | 1.60▼ | 1.70▼ |
| MA10 | 1.47▼ | 1.48▼ | 1.54▼ | 1.81▼ | 1.27▲ |
| MA20 | 1.46▼ | 1.56▼ | 1.58▼ | 1.80▼ | 1.01▲ |
| MA50 | 1.53▼ | 1.59▼ | 1.69▼ | 1.24▲ | 5.17▼ |
| MA100 | 1.59▼ | 1.73▼ | 1.90▼ | 1.02▲ | N/A |
| MA200 | 1.60▼ | 1.91▼ | 1.55▼ | 3.74▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.012▼ | -0.011▼ | -0.093▼ | 0.429▲ |
| RSI | 33.590▼ | 29.746▼ | 33.871▼ | 45.724▼ | 42.093▼ |
| STOCH | 8.144▼ | 9.583▼ | 3.985▼ | 8.082▼ | 57.502 |
| WILL %R | -90.909▼ | -97.872▼ | -97.959▼ | -97.887▼ | -62.081 |
| CCI | -49.885 | -74.805 | -107.708▼ | -100.593▼ | 69.229 |
|
Wednesday, August 06, 2025 11:41 PM
Gain insights into Neumora Therapeutics' Q2 2025 earnings, prioritizing obesity treatments, six upcoming clinical data readouts, & a strong cash runway ...
|
|
Wednesday, August 06, 2025 07:46 PM
Clinical pipeline advanced, with key Phase 3 trials in major depressive disorder and new studies entering clinic. These 10 stocks could mint the next wave of millionaires › Neumora Therapeutics ...
|
|
Wednesday, August 06, 2025 01:13 PM
Initiated Phase 1 single-ascending dose/multiple-ascending dose (SAD/MAD) study with M4 positive allosteric modulator (PAM) NMRA-861, with data expected in the first quarter of 2026 Announces ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/08/25 | 1.65 | 1.69 | 1.43 | 1.46 | 800,188 |
| 07/08/25 | 1.66 | 1.6994 | 1.5899 | 1.65 | 1,282,796 |
| 06/08/25 | 1.66 | 1.66 | 1.54 | 1.59 | 1,060,585 |
| 05/08/25 | 1.70 | 1.72 | 1.59 | 1.66 | 1,212,538 |
| 04/08/25 | 1.67 | 1.79 | 1.62 | 1.65 | 1,153,607 |
| 01/08/25 | 1.88 | 1.92 | 1.515 | 1.56 | 2,115,722 |
| 31/07/25 | 2.06 | 2.115 | 1.95 | 1.96 | 850,982 |
| 30/07/25 | 2.22 | 2.22 | 1.99 | 2.08 | 1,007,343 |
| 29/07/25 | 2.24 | 2.35 | 2.09 | 2.19 | 1,835,617 |
| 28/07/25 | 2.36 | 2.3992 | 2.115 | 2.28 | 2,564,121 |
|
|
||||
|
|
||||
|
|